A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and

Guillermo Flores-Delgado1, Cathy W Y Liu, Richard Sposto

  • 1Division Of Hematology/Oncology, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, 4650 Sunset Boulevard, Los Angeles, California 90027, USA.

Insights

Researchers identified novel protein phosphatase 1 (PP1)-interacting proteins (PIPs) crucial for cell proliferation and survival. These interactions are often specific to cell type and PP1 isoform, impacting cell cycle regulation and apoptosis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Protein phosphatase 1 (PP1) catalytic subunits interact with numerous proteins to regulate their function, substrate specificity, and localization.
  • Over 50 PP1-interacting proteins (PIPs) are known, but many more likely exist given the vast number of phosphoproteins in mammals.
  • Identifying novel PIPs is crucial for understanding PP1's diverse roles in cellular processes.

Purpose of the Study:

  • To identify novel PIPs involved in cell proliferation and survival using antibody arrays.
  • To investigate the cell type and isoform specificity of PP1 interactions.
  • To elucidate the functional significance of novel PP1 interactions in cancer cells.

Main Methods:

  • Utilized antibody arrays with 100 selected antibodies to screen for novel PIPs in murine fetal lung epithelial and human A549 lung cancer cells.
  • Confirmed novel interactions using co-immunoprecipitation assays.
  • Investigated specific PP1 interactions with Bax and the PP1alpha-SCF1 complex in A549 cells.

Main Results:

  • Identified 31 potential novel PIPs and 11 known PIPs, indicating an array sensitivity of at least 65%.
  • Confirmed interactions of 9 proteins with PP1, including APAF-1, Bax, E-cadherin, HSP-70, Id2, p19Skp1, p53, PCNA, and PTEN.
  • Demonstrated cell type- and isoform-specific interactions, with nicotine exposure affecting PP1-Bax association and PP1alpha associating with the SCF1 complex during specific cell cycle phases.

Conclusions:

  • Novel PIPs were identified, expanding the known interactome of PP1.
  • PP1 interactions are highly specific, contributing to its diverse regulatory functions.
  • Novel PP1 interactions with Bax and the SCF1 complex suggest roles in cell cycle arrest and apoptosis, potentially offering therapeutic targets.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...